Basic Information
LncRNA/CircRNA Name | circ_104075 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | hepatocellular cancer |
ICD-0-3 | NA |
Methods | Mouse experiments, Western blotting, qPCR, Dual luciferase analysis, ChIP, RNA-IP assay, Cell viability and colony formation assay, ELISA |
Sample | liver cancer tissues, liver cancer cell lines Bel-7402, SMMC-7721, Huh7, HepG2, Hep1, Bel-7404, the hepatocyte lines THLE-3, HL-7702, Serum samples |
Expression Pattern | up-regulated |
Function Description | circRNA_104075 (circ_104075) was highly expressed in HCC tissues, cell lines and serum. Mechanistically, HNF4a bound to the 1409 to 1401 region of the circ_104075 promoter to stimulate the expression of circ_104075. Moreover, circ_104075 acted as a ceRNA to upregulate YAP expression by absorbing miR-582-3p. Interestingly, an N6 - methyladenosine (m6 A) motif was identified in the 353 357 region of YAP 3 UTR, and this m6 A modification was essential for the interaction between miR-582-3p and YAP 3 UTR. Further, the diagnostic performance of circ_104075 was evaluated. The area under the receiver operating characteristic (AUC-ROC) for circ_104075 was 0.973 with a sensitivity of 96.0% and a specificity of 98.3%. Collectively, we determined that circ_104075 was highly expressed in HCC and elucidated its upstream and downstream regulatory mechanisms. |
Pubmed ID | 30361504 |
Year | 2018 |
Title | circRNA_104075 stimulates YAPdependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma |
External Links
Links for circ_104075 | GenBank HGNC NONCODE |
Links for hepatocellular cancer | OMIM COSMIC |